Investors Menu
Tilray® Exports Bulk Supply of Medical Cannabis Flower to Germany

Tilray becomes first and only company with both flower and oil medical cannabis products available in the German market NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 13, 2018-- Tilray, Inc ., (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production and distribution, today

September 13, 2018
Tilray® Exports 2:100 CBD Oil to the United Kingdom

Tilray is supplying medical cannabis to pediatric patient in need NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 11, 2018-- Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally

September 11, 2018
Tilray, Inc. Reports Second Quarter 2018 Earnings

Revenue rises 95.2% to US$9.7 million in second quarter and 75.2% to US$17.6 million in first half of 2018 Tilray medical cannabis products now available to patients in 11 countries on five continents Company has signed agreements to supply adult-use cannabis to consumers in seven Canadian

August 28, 2018
Tilray, Inc. to Present at the Barclays Global Consumer Staples Conference

NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 23, 2018-- Tilray, Inc., (“ Tilray” or the “Company”) (NASDAQ: TLRY) a global pioneer in cannabis production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, and Mark Castaneda , Chief Financial

August 23, 2018
Tilray to Report Second Quarter 2018 Financial Results on August 28, 2018

NANAIMO, British Columbia --(BUSINESS WIRE)--Aug. 7, 2018-- Tilray Inc. (Nasdaq: TLRY), a global pioneer in cannabis production and distribution, announced today it will report results for the second quarter ended June 30, 2018 on Tuesday, August 28, 2018 after market close.

August 7, 2018